Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental...
- Pfizer 's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed up trials of new experimental rivals, Wall Street analysts said.
At least three Wall Street brokerages said the withdrawal could create an immediate need to accelerate trials of rival drugs for the inherited condition, including Agios Pharmaceuticals' mitapivat and Fulcrum Therapeutics' pociredir.In case of Agios, it could create pressure on regulators to speed up the review, Piper Sandler analysts said.
Pfizer's shares were marginally down on Thursday. The stock is trading at around half its pandemic highs. At least five African countries are working on what could be the world's first joint "debt-for-nature" swap to raise at least $2 billion to protect a coral-rich swathe of Indian Ocean, according to a global conservation group. Debt-for-nature deals are becoming increasingly popular for poorer nations to pay for conservation. Bonds or loans are bought and replaced with cheaper debt, with savings used for environmental protection.
Wall Street Analysts Sickle Cell Disease Agios Pharmaceuticals Fulcrum Therapeutics Clinical Trials European Medicines Agency Oxbryta CRISPR Therapeutics Piper Sandler
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
S&P/TSX composite moves lower Wednesday, U.S. stock markets mixedTORONTO — Canada's main stock index edged lower on Wednesday, weighed down by the energy sector as the price of oil fell, while U.S. stock markets were mixed, with the S&P 500 and Dow slipping from the records set the day before.
Read more »
Wednesday’s analyst upgrades and downgrades for September 18, 2024Inside the Market’s roundup of some of today’s key analyst actions
Read more »
Hot, humid weather continues in Ottawa this WednesdayThe higher-than-average temperatures continue in Ottawa this Wednesday with a mix of sun and cloud.
Read more »
Factbox-Most brokerages expect 25 bps rate cut from Fed on WednesdayMajor brokerages expect the U.S. Federal Reserve to lower interest rates by 25 basis points at the end of its two-day monetary policy meeting that starts on ...
Read more »
Verdict in sex assault case of retired vice-admiral Edmundson expected WednesdayRetired vice-admiral Haydn Edmundson arrives to court in Ottawa on Thursday, Feb. 8, 2024. THE CANADIAN PRESS/Sean Kilpatrick
Read more »
S&P/TSX composite ends flat on Wednesday, U.S. stock markets mixedTORONTO — Weakness in the energy sector offset gains elsewhere to leave Canada's main stock index essentially flat Wednesday, while U.S. markets were mixed. The S&P/TSX composite index closed down 1.69 points at 23,040.76.
Read more »